Trial Profile
Phase 4 Study Comparison of Two Combined Oral Contraceptive Regimens and an Intravaginal Hormonal Ring Against Placebo for Management of Bleeding Problems in Women Using Implanon, the Sub-dermal Contraceptive Implant.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary) ; Ethinylestradiol/etonogestrel (Primary)
- Indications Metrorrhagia
- Focus Therapeutic Use
- 01 Jul 2011 Lead trial center (Family Planning Association New South Wales) added as reported by ClinicalTrials.gov.
- 01 Jul 2011 Planned end date (1 Apr 2013) added as reported by ClinicalTrials.gov.
- 01 Jul 2011 New source added and integrated (ClinicalTrials.gov, NCT01384331).